Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDay One Biopharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.48 | -$0.40 | -$0.44 |
| Q2 2025 | 7 | -$0.41 | -$0.25 | -$0.35 |
| Q3 2025 | 3 | -$0.33 | -$0.33 | -$0.33 |
| Q4 2025 | 3 | -$0.33 | -$0.33 | -$0.33 |
| Q1 2026 | 2 | -$0.30 | -$0.30 | -$0.30 |
| Q2 2026 | 4 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2026 | 3 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2026 | 3 | $0.01 | $0.01 | $0.01 |
Day One Biopharmaceuticals, Inc. Earnings Date And Information
Day One Biopharmaceuticals, Inc. last posted its earnings results on Tuesday, May 6th, 2025. The company reported $-0.35 earnings per share for the quarter, topping analysts' consensus estimates of $-0.46 by $0.11. The company had revenue of 30.76 M for the quarter and had revenue of 131.16 M for the year. Day One Biopharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-1.02 diluted earnings per share) and currently has a price-to-earnings ratio of -9.84. Day One Biopharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 29th, 2025 based on prior year's report dates.
Day One Biopharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2025 | Q1 2025 | -$0.46 | -$0.35 | 0.11 | $30.27 M | $30.76 M |
| 03/06/2025 | Q4 2024 | N/A | -$0.70 | N/A | $27.83 M | $29.21 M |
| 10/30/2024 | Q3 2024 | -$0.41 | $0.38 | 0.79 | $28.48 M | $93.76 M |
| 08/02/2024 | Q2 2024 | N/A | -$0.05 | N/A | $1.03 M | $8.19 M |
| 05/06/2024 | Q1 2024 | -$0.67 | -$0.72 | -0.05 | N/A | $0 |
| 02/26/2024 | Q4 2023 | -$0.57 | -$0.62 | -0.05 | N/A | $560.00 K |
| 11/06/2023 | Q3 2023 | -$0.60 | -$0.54 | 0.06 | N/A | $0 |
| 08/07/2023 | Q2 2023 | -$0.60 | -$0.61 | -0.01 | N/A | $0 |
| 05/01/2023 | Q1 2023 | -$0.60 | -$0.49 | 0.11 | N/A | $0 |
| 03/06/2023 | Q4 2022 | -$0.57 | -$0.47 | 0.1 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$0.53 | -$0.48 | 0.05 | N/A | $0 |
| 08/04/2022 | Q2 2022 | -$0.49 | -$0.60 | -0.11 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.39 | -$0.48 | -0.09 | N/A | $0 |
| 03/07/2022 | Q4 2021 | -$0.36 | -$1.93 | -1.57 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.28 | -$0.31 | -0.03 | N/A | $0 |
| 08/10/2021 | Q2 2021 | -$0.31 | -$0.23 | 0.08 | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.25 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$0.56 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$0.05 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.03 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Day One Biopharmaceuticals, Inc. Earnings: FAQ's
Day One Biopharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 29th, 2025 based offlast year's report dates.
In the previous quarter, Day One Biopharmaceuticals, Inc. (:DAWN) reported $-0.35 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.46 by $0.11.
The conference call for Day One Biopharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Day One Biopharmaceuticals, Inc.'s latest earnings report can be read online.
Day One Biopharmaceuticals, Inc. (:DAWN) has a recorded annual revenue of $131.16 M.
Day One Biopharmaceuticals, Inc. (:DAWN) has a recorded net income of $-95,496,000.Day One Biopharmaceuticals, Inc. has generated $-1.02 earnings per share over the last four quarters.
Day One Biopharmaceuticals, Inc. (:DAWN) has a price-to-earnings ratio of -9.84 and price/earnings-to-growth ratio is -0.29.